Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma.

about

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion

P2860

Q57072897-41B58F9F-C3A6-4844-8F20-B8A92C883E22

P2860

Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma.

Item

http://www.wikidata.org/entity/Q42700308

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prognostic value of programmed ...... ovarian clear cell carcinoma.

@en

Prognostic value of programmed death-ligand 1

@nl

type

Item

label

Prognostic value of programmed ...... ovarian clear cell carcinoma.

@en

Prognostic value of programmed death-ligand 1

@nl

prefLabel

Prognostic value of programmed ...... ovarian clear cell carcinoma.

@en

Prognostic value of programmed death-ligand 1

@nl

P1476

Prognostic value of programmed ...... ovarian clear cell carcinoma.

@en

P2093

Hao Wen

http://www.w3.org/2001/XMLSchema#string

Rui Bi

http://www.w3.org/2001/XMLSchema#string

Yong Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?

Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma

Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.

Cancer statistics, 2012

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

P304

e77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3802/JGO.2017.28.E77

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jun Zhu

Xiaohua Wu

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29027395

http://www.w3.org/2001/XMLSchema#string

P932

5641527

http://www.w3.org/2001/XMLSchema#string

Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma.

about

P2860

P2860

Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932